1. Intravitreal Injections and Face Masks: Endophthalmitis Risk Before and During the COVID-19 Pandemic
- Author
-
Saeed Karimi, Homayoun Nikkhah, Amir Mohammadzadeh, Alireza Ramezani, Iman Ansari, Hosein Nouri, and Seyed-Hossein Abtahi
- Subjects
covid-19 ,endophthalmitis ,face mask ,intravitreal injection ,infection ,Ophthalmology ,RE1-994 - Abstract
Abstract Purpose: To assess the added risk of acute endophthalmitis after intravitreal injections associated with the widespread use of face masks during the COVID-19 pandemic. Methods: In this retrospective, single-center study, records of patients with acute endophthalmitis following intravitreal bevacizumab (IVB) injections during the pre-COVID era—that is, March 1 st , 2013 to October 31 st , 2019 —and the COVID-19 era—that is, March 1 st , 2020 to April 1 st , 2021 —were reviewed and compared. Results: A total of 28,085 IVB injections were performed during the pre-COVID era; nine eyes of nine patients developed acute post-IVB endophthalmitis in this era, giving an overall incidence of 0.032% (3.2 in 10,000 injections). In the COVID era, 10,717 IVB injections were performed; four eyes of four patients developed acute post-IVB endophthalmitis in this era, giving an overall incidence of 0.037% (3.7 in 10,000 injections). The incidences of post-IVB endophthalmitis during these two eras were not statistically significantly different (P = 0.779). Conclusion: Face masking protocols seem unlikely to impose any additional risk of post-IVB endophthalmitis.
- Published
- 2023
- Full Text
- View/download PDF